Longevity Science: Time To Turn Back Time

The appeal of living a healthier and longer life is clear. It’s also becoming an increasing reality. Think of the human body as just another piece of hardware to be hacked, optimised and upgraded. Longevity science is a developing discipline that embraces genetics, biology, medicine and technology. It matters since an ageing population with growing chronic conditions raises the cost of health and social care. Advances in longevity science are helping to shift the healthcare paradigm from reaction to pre-emption, improving the capabilities of already healthy people. Multiple moonshots are underway. Many will fail and others will encounter practical, scientific and ethical issues. However, over $8bn of venture capital flowed into the sector in 2024. Businesses want even a small share of the $600bn longevity-focused healthcare market. Equity investors have multiple ways of playing this theme, which we expect only to grow in importance.